Insider trade

Passage Bio (PASG)10% owner bought ~$206K

Lynx1 Capital Management LP, 10% owner at Passage Bio, bought ~$206K of Passage Bio shares.

~$206K
Approx. value · 50K sh @ $4.12: 674K
Holds after · shares reported

Traded: Jun 25, 2026
Filed: Jun 30, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Apr 28, 2026Company filing · Form 8-K · RestructuringAnnounced job cuts, closures or a restructuring“As part of its previously announced efforts to review strategic alternatives to maximize shareholder value, on April 28, 2026, Passage Bio, Inc. (the “ Company ”) announced a restructuring of its workforce (the “ Restructuring Plan ”) to decrease its operating expenses by reducing the workforce by approximately 75%.”
May 21, 2026Company filing · Form 8-K · Agreement endedEnded an important agreement
Jun 23, 2026Company filing · Form 8-K · Material agreement, Agreement endedControl of the company changed hands, and changed a top executive or board member (and 5 more items)“On June 24, 2026, Passage Bio and Remix issued a joint press release announcing the execution of the Merger Agreement. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference, except that the information contained on the websites referenced in the press release is not incorporated herein by reference.”
Jun 25, 2026 · this disclosureInsider10% owner purchased ~$206K of PASG shares in the open market

What came next

Sep 2, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Passage Bio

OQRO holds no insider, Congress, fund or contract record for Passage Bio dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PASG page.

Other recent filings by Lynx1 Capital Management LP, 10% owner

The full history of Lynx1 Capital Management LP, 10% owner is on the profile page.

How this filing works

Other disclosures at Passage Bio

Everything OQRO holds on this company is on its PASG page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data